Business Segments · Goodwill (Note 11)

United States — Goodwill (Note 11)

Edwards Lifesciences United States — Goodwill (Note 11) decreased by 1.3% to $1.12B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $1.14B to $1.12B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
Rolls up toGoodwill

How to read this metric

An increase suggests recent acquisitions or adjustments in the U.S. segment, while a decrease may indicate impairment charges or divestitures.

Detailed definition

Represents the total carrying value of goodwill allocated to the United States geographic reporting segment. This asset...

Peer comparison

Standard across most public companies reporting segment-level intangible assets under GAAP.

Metric ID: ew_segment_united_states_goodwill_note_11

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$773.70M$773.70M$773.70M$1.14B$1.12B
QoQ Change+0.0%+0.0%+47.3%-1.3%
YoY Change+0.0%+0.0%+47.3%-1.3%
Range$773.70M$1.14B
CAGR+45.4%
Avg YoY Growth+11.5%
Median YoY Growth+0.0%

Frequently Asked Questions

What is Edwards Lifesciences's united states — goodwill (note 11)?
Edwards Lifesciences (EW) reported united states — goodwill (note 11) of $1.12B in Q4 2025.
How has Edwards Lifesciences's united states — goodwill (note 11) changed year-over-year?
Edwards Lifesciences's united states — goodwill (note 11) decreased by 1.3% year-over-year, from $1.14B to $1.12B.
What does united states — goodwill (note 11) mean?
The total value of goodwill recorded for the company's United States business operations.